top of page
Blog.jpg

Blog posts provide the latest information on our project activities, 
newsletters and other noteworthy events

TSRG Annual Letter 2024

TSRG Annual Letter 2024

January 1, 2024

The year 2023 was an important year for TSRG. Please find the details in our annual letter and our plans for 2024!

TSRG Newsletter Q4 2023

TSRG Newsletter Q4 2023

December 7, 2023

TSRG’s fourth quarterly newsletter is now published. Find team updates, details on ongoing projects, a year end fundraising recap, and more!

TSRG Newsletter Q3 2023

TSRG Newsletter Q3 2023

September 2, 2023

TSRG’s third quarterly newsletter is now published. Find out details about our new projects, updates on ongoing projects, how you can...

TSRG Newsletter Q2 2023

TSRG Newsletter Q2 2023

June 1, 2023

TSRG’s second quarterly newsletter is now published. Find updates on HRSA Implementation, A Path Forward Podcast, Team Updates, and more!...

Introducing TSRG’s Quarterly Newsletter: A Path Forward

Introducing TSRG’s Quarterly Newsletter: A Path Forward

March 1, 2023

TSRG’s second quarterly newsletter is now published. Find updates on HRSA Implementation, A Path Forward Podcast, Team Updates, and more!...

TSRG Annual Letter 2023

TSRG Annual Letter 2023

January 1, 2023

The year 2022 was an important year for TSRG. Please find the details in our annual letter and our plans for 2023!

TSRG Annual Letter 2022

TSRG Annual Letter 2022

January 1, 2022

MISSION STATEMENT Our mission is to improve outcomes associated with addiction-prone substances through community outreach and research.

TSRG Annual Letter 2021

TSRG Annual Letter 2021

January 1, 2021

Welcome 2021!   As I reflect on 2020, a time of COVID, uncertainty, and great achievement, I am humbled by what the new year may bring. ...

Disclaimer (Last updated: December 3, 2024) The information contained on the tsrg.org website is for general information purposes only. The Schreiber Research Group does not take a policy position and reserves the right to make additions, deletions, or modifications to the contents at any time without prior notice.

Images used under license from Shutterstock.com (Homepage, Blog, Contact Us, Donate, Our Team and Research). Artwork on the Benzodiazepine webpage was created by Akhtar Badshah (Kirkland, WA). The Path Forward logo was designed by Salem Hansen (Aurora, CO, Los Angeles, CA). 

Contact Us

Phone: +1 720-234-8191

Email: terri@tsrg.org

P.O. Box 371342

Denver, CO 80237

FEIN : 83-2233301

  • Facebook
  • LinkedIn
bottom of page